Department of Physics, University of Würzburg, Würzburg, Germany.
Radiother Oncol. 2010 Jul;96(1):123-30. doi: 10.1016/j.radonc.2010.05.006. Epub 2010 Jun 11.
To correlate non-invasively acquired radiobiologically relevant magnetic resonance (MR) parameters with functional histology and tumor control doses (TCD(50)).
The MR parameters relative perfusion, re-oxygenation and lactate (Lac) concentration from eight human xenograft squamous tumor lines were compared with the histologically acquired pimonidazole hypoxic fraction, the perfused vessel area and TCD(50).
Good spatial correlation in the parameter maps could be observed between the pimonidazole staining and tumor regions, which can be reoxygenated when breathing carbogen. A strong positive correlation (R=0.74) was found between whole tumor pimonidazole hypoxic fraction and re-oxygenation, as one would expect. A good correlation was also observed between Lac concentration and re-oxygenation (R=0.71) and between TCD(50) and re-oxygenation (R=0.64), whereas Lac and TCD(50) showed a moderate relation (R=0.44). The in vivo measurement of relative perfusion could be validated to reflect the perfused vessel area (R=0.63). No correlation was detected between perfusion and re-oxygenation or TCD(50).
Lac and re-oxygenation were shown to be pretreatment predictive markers independent from the pathophysiological changes induced during a fractionated course of radiotherapy. These parameters hold promise to be acquired non-invasively with results just a few minutes after measurement and to tailor radiotherapy to individual patterns of a tumor microenvironment.
无创获取放射生物学相关的磁共振(MR)参数,并将其与功能组织学及肿瘤控制剂量(TCD(50))相关联。
将 8 个人类异种移植鳞癌系的 MR 参数(相对灌注、再氧合和乳酸(Lac)浓度)与组织学获取的吡莫硝唑低氧分数、灌注血管面积和 TCD(50)进行比较。
可在吡莫硝唑染色和肿瘤区域之间的参数图中观察到良好的空间相关性,这些区域在呼吸卡波济气时可以再氧合。整个肿瘤吡莫硝唑低氧分数与再氧合之间存在强烈的正相关(R=0.74),这是意料之中的。Lac 浓度与再氧合(R=0.71)以及 TCD(50)与再氧合(R=0.64)之间也存在良好的相关性,而 Lac 和 TCD(50)之间则呈现中等相关性(R=0.44)。相对灌注的体内测量可以被验证为反映灌注血管面积(R=0.63)。灌注与再氧合或 TCD(50)之间没有相关性。
Lac 和再氧合是独立于放射治疗分割过程中诱导的病理生理变化的治疗前预测标志物。这些参数有望在数分钟后获得无创结果,并根据肿瘤微环境的个体模式调整放射治疗。